Molbio Diagnostics LTD
₹1,507.00▲ +198.10 (+15.13%)
MOLBIO·NSE·Healthcare
Market Cap
14635.48 Cr
PE Ratio
117.46
Volume
87,51,648
Day High - Low
1564.30 - 1312.10
52W High-Low
1686.80 - 926.35
₹1,507.00▲ +198.10 (+15.13%)
Market Cap14635.48 Cr
PE Ratio117.46
Volume87,51,648
Day High - Low1564.30 - 1312.10
52W High-Low1686.80 - 926.35
Molbio Diagnostics Ltd (MOLBIO): company summary
Molbio Diagnostics Ltd (MOLBIO) is a small-cap Healthcare company valued at ₹14,635 crore operating in Healthcare Equipment & Supplies on the NSE and BSE.
Molbio Diagnostics Ltd (MOLBIO) is a small-cap Healthcare company valued at ₹14,635 crore operating in Healthcare Equipment & Supplies on the NSE and BSE.
- Recent price move
- Molbio Diagnostics Ltd last traded at ₹1,507, sharply up 15.13% on the day.
- Financial performance
- Revenue has been growing strongly at 58.9% a year over three years; profit grew 108.5% a year, ahead of revenue — margins are expanding. Return on equity is 14.8%.
- Valuation multiples
- The stock trades at 117.5 times earnings, a premium to the Healthcare median of 32.4, 12.70 times book value.
Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
DocStoX Score
3.4/10
Poor
Fair Value
Sign in to see
ROE
14.80%
Average
P/E
117.46x
Expensive
Debt / Equity
0.03
Low
Industry
Healthcare
Healthcare Equipment & Supplies
Overall View
Mixed
Price performance
Day₹1312
₹1564
52W₹926.35
₹1687
DocStoX take
Supported by risk (7.5) and momentum (7.5), but held back by valuation (0.0). Risk looks strong at 7.5, but that is offset by valuation at 0.0 and growth at 0.1. We are calling it Mixed rather than resolving the conflict for you.
DocStoX score
Low confidence3.4
/10
Poor
Quality
Solid
ROE 14.8%
Valuation
Expensive
P/E 117.5×
Growth
Flat
Revenue +0.7% 5Y CAGR
Risk
Low risk
D/E 0.03
Momentum
Strong
76% of 52-week range
At a glance
Market Cap
₹14,635 Cr
52W High / Low
₹1687 / ₹926
Dividend Yield
0.00%
Promoter Holding
41.29%
EPS (TTM)
₹12.83
Book Value
₹118.84
Key highlights
- Low leverage — D/E 0.03
- Profitable in all of the last 5 years
- Capital works hard — ROCE 22%
- Profit shrinking 19% a year
- Valuation is weak (0.0/10)
3 Positives4 Watchouts
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Healthcare Equipment & Supplies
Explore MOLBIO DIAGNOSTICS LTD’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
MOLBIO DIAGNOSTICS LTD peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
SUN PHARMACEUTICAL IND LDIVI S LABORATORIES LTDTORRENT PHARMACEUTICALS LAPOLLO HOSPITALS ENTER. LZYDUS LIFESCIENCES LTDCIPLA LTDLAURUS LABS LIMITEDMANKIND PHARMA LIMITEDDR. REDDY S LABORATORIESMANIPAL HEALTH ENTERPRI LAUROBINDO PHARMA LTDLUPIN LIMITED
Compare MOLBIO DIAGNOSTICS LTD with peers
Related tools & concepts
Value MOLBIO DIAGNOSTICS LTD with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing